testolactone has been researched along with Prostatic Hyperplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekman, P | 1 |
| Honma, S; Ito, K; Suzuki, K; Suzuki, T; Tamura, Y; Yamanaka, H | 1 |
| Bartsch, W; Klein, H; Stürenburg, HJ; Voigt, KD | 1 |
1 trial(s) available for testolactone and Prostatic Hyperplasia
| Article | Year |
|---|---|
Endocrine therapy for benign prostatic hyperplasia in the 90's.
Topics: Androstenedione; Aromatase Inhibitors; Controlled Clinical Trials as Topic; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Placebos; Prostatic Hyperplasia; Testolactone | 1995 |
2 other study(ies) available for testolactone and Prostatic Hyperplasia
| Article | Year |
|---|---|
Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: changes in prostate volume and histopathological findings.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Carrier Proteins; Castration; Dogs; Estramustine; Immunoenzyme Techniques; Male; Organ Size; Prostate; Prostatic Hyperplasia; Prostatic Secretory Proteins; Stromal Cells; Testolactone | 1996 |
Metabolism of androgens in human benign prostatic hyperplasia: aromatase and its inhibition.
Topics: 17-Hydroxysteroid Dehydrogenases; Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Estrone; Humans; Male; Microsomes; Placenta; Prostate; Prostatic Hyperplasia; Testolactone | 1987 |